Bitdeer Technologies (BTDR)

=== SEC Form 3 — Statement of Changes in Beneficial Ownership === Document Type: 3 Period of Report: 2026-03-18 --- Issuer --- Name: Bitdeer Technologies Group (BTDR) CIK: 0001899123 --- Reporting Owner --- Name: Naas Lars Eivind Haugnes CIK: 0002122132 Role: Director --- Holdings --- [Holding #1] Security: Class A Ordinary Shares Ownership: D (Direct) [Holding #2] Security: Class A Ordinary Shares Ownership: I (Indirect) Footnotes: [F1] These shares are held directly by Renol Invest AS. LEHN Invest 2 AS, an entity wholly owned by the Reporting Person, holds a 28.33% ownership interest in Renol Invest AS. The Reporting Person serves as the Chairman of the board of directors of Renol Invest AS and shares voting and dispositive power over the shares held by Renol Invest AS with the other directors. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended, the Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. [Holding #3] Security: Class A Ordinary Shares Ownership: I (Indirect) Footnotes: [F2] These shares are held directly by LEHN Invest 2 AS. The Reporting Person is the sole shareholder and sole director of LEHN Invest 2 AS, and has sole voting and dispositive power over the shares held by LEHN Invest 2 AS. [Holding #4] Security: Share Option (right to buy) Ownership: D (Direct) Footnotes: [F3] 20% of the total shares subject to the option have become vested and exercisable on January 1, 2026, and remaining shares subject to the option shall become vested annually in equal installments of 20% on January 1st of each of the four subsequent years, subject to the Reporting Person's continued service with the Issuer on each such vesting date. --- Footnotes (Complete Index) --- F1: These shares are held directly by Renol Invest AS. LEHN Invest 2 AS, an entity wholly owned by the Reporting Person, holds a 28.33% ownership interest in Renol Invest AS. The Reporting Person serves as the Chairman of the board of directors of Renol Invest AS and shares voting and dispositive power over the shares held by Renol Invest AS with the other directors. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended, the Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. F2: These shares are held directly by LEHN Invest 2 AS. The Reporting Person is the sole shareholder and sole director of LEHN Invest 2 AS, and has sole voting and dispositive power over the shares held by LEHN Invest 2 AS. F3: 20% of the total shares subject to the option have become vested and exercisable on January 1, 2026, and remaining shares subject to the option shall become vested annually in equal installments of 20% on January 1st of each of the four subsequent years, subject to the Reporting Person's continued service with the Issuer on each such vesting date. --- Signature --- /s/ /s/ Lars Eivind Haugnes Naas (2026-03-31)